Tomonori Oura
Tomonori Oura publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery, on topics such as Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins and Diabetes Management and Research.
- World rank
- #934,784 of 7,710,434 ranked researchers
- Rank in Japan
- #12,257 of 383,136
- Works
- 59
- Citations
- 1.5k
- Citations per work
- 25.1
What does Tomonori Oura research?
Tomonori Oura's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3660.4%
- Medicine3660.4%
- Everything else1322.5%
- Life Sciences1017.1%
- 1Endocrinology, Diabetes and Metabolism40% of their works
- 2Molecular Biology14% of their works
- 3Surgery10% of their works
- 4Pharmacology6% of their works
- 5Cardiology and Cardiovascular Medicine4% of their works
- 6Genetics3% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Bariatric Surgery and Outcomes
- Pharmacology and Obesity Treatment
- Metabolism, Diabetes, and Cancer
- Pancreatic function and diabetes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Which keywords describe Tomonori Oura's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Diabetes, Cardiovascular Outcomes, Glucose Control, Obesity and Cardiovascular Disease.
- Critical Care
- Pancreatic Islets
- AMP-Activated Protein Kinase
- Diabetes Mellitus
- Metabolic Surgery
- Hypoglycemia
- Metabolic Syndrome
- Weight Loss
- Cardiovascular Disease
- Glucose Control
- Diabetes
- Insulin Therapy
- Glycemic Control
- Type 2 Diabetes
- Cardiovascular Outcomes
- Obesity
- Lifestyle Intervention
- Insulin Resistance
- Continuous Glucose Monitoring
- Bariatric Surgery
- Anti-Obesity Drugs
- Pharmacotherapy
- Metformin
- ß-Cell Dysfunction
- Hyperglycemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 25 words, with their numbers
- Glycemic Control463 topics
- Insulin Therapy463 topics
- Type 2 Diabetes412 topics
- Diabetes333 topics
- Cardiovascular Outcomes311 topic
- Glucose Control311 topic
- Obesity313 topics
- Cardiovascular Disease232 topics
- Lifestyle Intervention222 topics
- Weight Loss192 topics
- Insulin Resistance121 topic
- Metabolic Syndrome121 topic
- Continuous Glucose Monitoring111 topic
- Hypoglycemia111 topic
- Bariatric Surgery101 topic
- Metabolic Surgery101 topic
- Anti-Obesity Drugs91 topic
- Diabetes Mellitus92 topics
- Pharmacotherapy91 topic
- AMP-Activated Protein Kinase61 topic
- Metformin61 topic
- Pancreatic Islets51 topic
- ß-Cell Dysfunction51 topic
- Critical Care41 topic
- Hyperglycemia41 topic
Where does Tomonori Oura work?
Tomonori Oura's main affiliation in the publication record is Eli Lilly (Japan), Japan.
How many publications and citations does Tomonori Oura have?
OpenAlex counts 59 works and 1,478 citations for Tomonori Oura, an h-index of 18, ranking #934,784 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tomonori Oura. Posts are plain text and can be reported.